Senestech (SNES) Projected to Post Earnings on Wednesday

Senestech (NASDAQ:SNES) is expected to issue its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect the company to post earnings of ($0.37) per share and revenue of $0.6020 million for the quarter. Parties may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 5:00 PM ET.

Senestech (NASDAQ:SNES) last announced its quarterly earnings data on Tuesday, May 12th. The company reported ($0.31) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.02. The company had revenue of $0.49 million for the quarter, compared to analysts’ expectations of $0.63 million. Senestech had a negative return on equity of 67.60% and a negative net margin of 304.22%. On average, analysts expect Senestech to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Senestech Price Performance

Shares of SNES opened at $1.35 on Monday. The firm has a market cap of $7.16 million, a P/E ratio of -0.71 and a beta of 0.28. The stock has a 50 day simple moving average of $1.54 and a two-hundred day simple moving average of $1.74. The company has a debt-to-equity ratio of 0.02, a current ratio of 8.91 and a quick ratio of 7.79. Senestech has a 1 year low of $1.22 and a 1 year high of $6.24.

Insiders Place Their Bets

In related news, major shareholder Glenbrook Capital Management purchased 35,000 shares of the firm’s stock in a transaction on Monday, July 20th. The shares were acquired at an average cost of $1.47 per share, with a total value of $51,450.00. Following the purchase, the insider directly owned 1,057,824 shares of the company’s stock, valued at approximately $1,555,001.28. This trade represents a 3.42% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. In the last three months, insiders bought 143,773 shares of company stock worth $224,802. Corporate insiders own 2.20% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Renaissance Technologies LLC grew its holdings in Senestech by 35.2% in the 4th quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock worth $306,000 after acquiring an additional 37,165 shares during the last quarter. DRW Securities LLC raised its stake in shares of Senestech by 171.1% during the fourth quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock valued at $176,000 after acquiring an additional 51,818 shares during the last quarter. Jane Street Group LLC bought a new stake in shares of Senestech in the second quarter worth about $161,000. Millennium Management LLC purchased a new position in Senestech during the 3rd quarter valued at about $126,000. Finally, XTX Topco Ltd purchased a new position in Senestech during the 4th quarter valued at about $54,000. 5.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of Senestech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold”.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.